Welcome to LookChem.com Sign In|Join Free

CAS

  • or

67630-00-6

Post Buying Request

67630-00-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

67630-00-6 Usage

Description

(S)-ethyl 2-(tert-butoxycarbonylamino)-3-(4-nitrophenyl)propanoate, a chemical compound with the molecular formula C16H22N2O6, is a derivative of the amino acid proline. It is characterized by its potential to be converted into its active form within the body, classifying it as a prodrug. (S)-ethyl 2-(tert-butoxycarbonylaMino)-3-(4-nitrophenyl)propanoate is frequently utilized in organic synthesis and pharmaceutical research, serving as a precursor in the synthesis of various pharmaceuticals and in the development of novel drug compounds. Additionally, it is employed as a reagent in the production of other organic compounds and is under investigation for its possible therapeutic applications.

Uses

Used in Pharmaceutical Research and Development:
(S)-ethyl 2-(tert-butoxycarbonylamino)-3-(4-nitrophenyl)propanoate is used as a precursor in the pharmaceutical industry for the synthesis of various pharmaceuticals. Its role as a prodrug allows for the development of novel drug compounds that can be converted into their active forms within the body, enhancing their efficacy and potential therapeutic applications.
Used in Organic Synthesis:
In the field of organic chemistry, (S)-ethyl 2-(tert-butoxycarbonylamino)-3-(4-nitrophenyl)propanoate is utilized as a reagent for the production of other organic compounds. Its unique structure and properties make it a valuable component in the synthesis of a wide range of chemical products.
Used in Therapeutic Applications:
(S)-ethyl 2-(tert-butoxycarbonylamino)-3-(4-nitrophenyl)propanoate is widely studied for its potential therapeutic applications. As a prodrug, it offers the possibility of improved drug delivery and enhanced bioavailability, making it a promising candidate for the development of new treatments in various medical fields.

Check Digit Verification of cas no

The CAS Registry Mumber 67630-00-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,7,6,3 and 0 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 67630-00:
(7*6)+(6*7)+(5*6)+(4*3)+(3*0)+(2*0)+(1*0)=126
126 % 10 = 6
So 67630-00-6 is a valid CAS Registry Number.

67630-00-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl N-{[(2-methyl-2-propanyl)oxy]carbonyl}-4-nitro-L-phenylalan inate

1.2 Other means of identification

Product number -
Other names N-tert-butoxycarbonyl-4-nitro-L-phenylalanine ethyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:67630-00-6 SDS

67630-00-6Relevant articles and documents

Fluorescent amino acid derivatives

-

Page/Page column 8, (2011/04/26)

The subject of the present invention is to provide a fluorescent substance excitable under visible light, having higher photostability and a long fluorescence lifetime. Another subject is to provide a fluorescent substance consists of a non-natural amino

VLA-4 ANTAGONISTS

-

Page/Page column 18, (2008/06/13)

Compounds of Formula I are antagonists of VLA-4, and as such are useful in the inhibition or prevention of cell adhesion and cell-adhesion mediated pathologies. These compounds may be formulated into pharmaceutical compositions and are suitable for use in the treatment of inflammatory bowel disease including ulcerative colitis and Crohn’s disease, multiple sclerosis, asthma, and rheumatoid arthritis.

Modulation of melphalan resistance in glioma cells with a peripheral benzodiazepine receptor ligand-melphalan conjugate

Kupczyk-Subotkowska, Lidia,Siahaan, Teruna J.,Basile, Anthony S.,Friedman, Henry S.,Higgins, Patricia E.,Song, Di,Gallo, James M.

, p. 1726 - 1730 (2007/10/03)

Peripheral benzodiazepine receptors (PBRs) are located on the outer membrane of mitochondria, and their density is increased in brain tumors. Thus, they may serve as a unique intracellular and selective target for antineoplastic agents. A PBR ligand-melph

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 67630-00-6